121 related articles for article (PubMed ID: 22648938)
1. Current issues and controversies in the classification of pediatric hepatocellular tumors.
López-Terrada D; Zimmermann A
Pediatr Blood Cancer; 2012 Nov; 59(5):780-4. PubMed ID: 22648938
[TBL] [Abstract][Full Text] [Related]
2. MT1G hypermethylation: a potential prognostic marker for hepatoblastoma.
Sakamoto LH; DE Camargo B; Cajaiba M; Soares FA; Vettore AL
Pediatr Res; 2010 Apr; 67(4):387-93. PubMed ID: 20032811
[TBL] [Abstract][Full Text] [Related]
3. Hepatoblastoma: recent developments in research and treatment.
von Schweinitz D
Semin Pediatr Surg; 2012 Feb; 21(1):21-30. PubMed ID: 22248967
[TBL] [Abstract][Full Text] [Related]
4. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.
Zynger DL; Gupta A; Luan C; Chou PM; Yang GY; Yang XJ
Hum Pathol; 2008 Feb; 39(2):224-30. PubMed ID: 17949790
[TBL] [Abstract][Full Text] [Related]
5. Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy.
Czauderna P; Lopez-Terrada D; Hiyama E; Häberle B; Malogolowkin MH; Meyers RL
Curr Opin Pediatr; 2014 Feb; 26(1):19-28. PubMed ID: 24322718
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin and met deregulation in childhood Hepatoblastomas.
Ranganathan S; Tan X; Monga SP
Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454
[TBL] [Abstract][Full Text] [Related]
7. Myc target miRs and liver cancer: small molecules to get Myc sick.
Buendia MA; Bourre L; Cairo S
Gastroenterology; 2012 Feb; 142(2):214-8. PubMed ID: 22178210
[No Abstract] [Full Text] [Related]
8. Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas.
Stejskalová E; Malis J; Snajdauf J; Pýcha K; Urbánková H; Bajciová V; Starý J; Kodet R; Jarosová M
Cancer Genet Cytogenet; 2009 Oct; 194(2):82-7. PubMed ID: 19781440
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
[TBL] [Abstract][Full Text] [Related]
10. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
[TBL] [Abstract][Full Text] [Related]
12. [TNM classification--pediatric tumors].
Hayashi Y; Ohi R; Okabe I; Todo S; Iwafuchi M; Tsuchida Y; Takahashi H; Ohnuma N; Hashizume K; Miyano T; Saeki M; Honna T; Yokoyama J; Nishi T; Toyosaka A; Suita S; Yamasaki S
Gan To Kagaku Ryoho; 1998 Feb; 25(3):431-41. PubMed ID: 9492841
[TBL] [Abstract][Full Text] [Related]
13. The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis.
Zimmermann A
Eur J Cancer; 2005 Jul; 41(11):1503-14. PubMed ID: 15982867
[TBL] [Abstract][Full Text] [Related]
14. Hepatoblastoma. An attempt to apply histologic classification to aspirates obtained by fine needle aspiration cytology.
Sola Pérez J; Pérez-Guillermo M; Bas Bernal AB; Mercader JM
Acta Cytol; 1994; 38(2):175-82. PubMed ID: 8147208
[TBL] [Abstract][Full Text] [Related]
15. A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
Cairo S; Armengol C; Maibach R; Häberle B; Becker K; Carrillo-Reixach J; Guettier C; Vokuhl C; Schmid I; Buendia MA; Branchereau S; von Schweinitz D; Kappler R
Eur J Cancer; 2020 Dec; 141():30-39. PubMed ID: 33125945
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic abnormalities in hepatoblastoma: report of two new cases and review of the literature suggesting imbalance of chromosomal regions on chromosomes 1, 4, and 12.
Nagata T; Nakamura M; Shichino H; Chin M; Sugito K; Ikeda T; Koshinaga T; Fukuzawa M; Inoue M; Mugishima H
Cancer Genet Cytogenet; 2005 Jan; 156(1):8-13. PubMed ID: 15588850
[TBL] [Abstract][Full Text] [Related]
17. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
18. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium.
López-Terrada D; Alaggio R; de Dávila MT; Czauderna P; Hiyama E; Katzenstein H; Leuschner I; Malogolowkin M; Meyers R; Ranganathan S; Tanaka Y; Tomlinson G; Fabrè M; Zimmermann A; Finegold MJ;
Mod Pathol; 2014 Mar; 27(3):472-91. PubMed ID: 24008558
[TBL] [Abstract][Full Text] [Related]
19. Hepatoblastoma: a clinico-pathologic review.
Pollice L; Zito FA; Troia M
Pathologica; 1992; 84(1089):25-32. PubMed ID: 1323095
[TBL] [Abstract][Full Text] [Related]
20. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
